Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DWG, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003;71(1):115–23.
Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis. 1983;147(4):676–84.
Article CAS PubMed Google Scholar
Hirsch HH, Randhawa PS. BK polyomavirus in solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13528.
Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006;20(4):401–9.
Bechert CJ, Schnadig VJ, Payne DA, Dong J. Monitoring of BK viral load in renal allograft recipients by real-time PCR assays. Am J Clin Pathol. 2010;133(2):242–50.
Article CAS PubMed Google Scholar
Helanterä I, Egli A, Koskinen P, Lautenschlager I, Hirsch HH. Viral impact on long-term kidney graft function. Infect Dis Clin North Am. 2010;24(2):339–71.
Schachtner T, Stein M, Babel N, Reinke P. The loss of BKV-specific immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased Risk of BKV replication. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2015;15(8):2159–69.
Schaub S, Hirsch HH, Dickenmann M, Steiger J, Mihatsch MJ, Hopfer H, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2010;10(12):2615–23.
Demey B, Tinez C, François C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2018;109:6–12.
Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Schnitzler MA, Major EO, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2005;5(9):2213–21.
Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, et al. Correlation of BK virus neutralizing serostatus with the incidence of BK Viremia in kidney transplant recipients. Transplantation. 2017;101(6):1495–505.
Article CAS PubMed Google Scholar
Sharif A, Alachkar N, Bagnasco S, Geetha D, Gupta G, Womer K, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(8):1320–7.
Article PubMed PubMed Central Google Scholar
Gorriceta JH, Lopez Otbo A, Uehara G, Posadas Salas MA. BK viral infection: A review of management and treatment. World J Transplant. 2023;13(6):309–20.
Article PubMed PubMed Central Google Scholar
Mohammadi Najafabadi M, Soleimani M, Ahmadvand M, Soufi Zomorrod M, Mousavi SA. Treatment protocols for BK virus associated hemorrhagic cystitis after hematopoietic stem cell transplantation. Am J Blood Res. 2020;10(5):217–30.
PubMed PubMed Central Google Scholar
Blazquez-Navarro A, Schachtner T, Stervbo U, Sefrin A, Stein M, Westhoff TH, et al. Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach. PLoS Comput Biol. 2018;14(5):e1005998.
Article PubMed PubMed Central Google Scholar
Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, Kuroda MJ, et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol. 2006;80(7):3495–505.
Article CAS PubMed PubMed Central Google Scholar
Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S. Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation. 2008;85(2):185–92.
Article CAS PubMed Google Scholar
Ottaviano G, Chiesa R, Feuchtinger T, Vickers MA, Dickinson A, Gennery AR, et al. Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation. Cells. 2019;8(1):47.
Article CAS PubMed PubMed Central Google Scholar
Nelson AS, Heyenbruch D, Rubinstein JD, Sabulski A, Jodele S, Thomas S, et al. Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients. Blood Adv. 2020;4(22):5745–54.
Olson A, Lin R, Marin D, Rafei H, Bdaiwi MH, Thall PF, et al. Third-party BK virus-specific cytotoxic t lymphocyte therapy for hemorrhagic cystitis following allotransplantation. J Clin Oncol Off J Am Soc Clin Oncol. 2021;39(24):2710–9.
Khoury R, Grimley MS, Nelson AS, Leemhuis T, Cancelas JA, Cook E, et al. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2024;24(9):1634–43.
Hopfner F, Möhn N, Eiz-Vesper B, Maecker-Kolhoff B, Gottlieb J, Blasczyk R, et al. Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy. Neurol Neuroimmunol neuroinflammation. 2021;8(4):e1020.
Rudilla F, Carrasco-Benso MP, Pasamar H, López-Montañés M, Andrés-Rozas M, Tomás-Marín M, et al. Development and characterization of a cell donor registry for virus-specific T cell manufacture in a blood bank. HLA. 2024;103(3): e15419.
Article CAS PubMed Google Scholar
Enrich E, Campos E, Martorell L, Herrero MJ, Vidal F, Querol S, et al. HLA-A, -B, -C, -DRB1, and -DQB1 allele and haplotype frequencies: An analysis of umbilical cord blood units at the Barcelona Cord Blood Bank. HLA. 2019;94(4):347–59.
Article CAS PubMed Google Scholar
BurekKamenaric M, Ivkovic V, KovacevicVojtusek I, Zunec R. The Role of HLA and KIR immunogenetics in BK Virus infection after kidney transplantation. Viruses. 2020;12(12):1417.
Chevalier MF, Allain V, Gras J, Racle J, Villemonteix J, Divard G, et al. Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation. Sci Adv. 2025;11(10):eadt3499.
Article CAS PubMed Google Scholar
Mani J, Wang L, Hückelhoven AG, Schmitt A, Gedvilaite A, Jin N, et al. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance. Oncotarget. 2017;8(2):2485–500.
Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, et al. T-cell responses to peptide fragments of the BK virus T antigen: Implications for cross-reactivity of immune response to JC virus. J Gen Virol. 2006;87(10):2951–60.
Article CAS PubMed Google Scholar
Provenzano M, Bracci L, Wyler S, Hudolin T, Sais G, Gosert R, et al. Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors. J Transl Med. 2006;4:1–15.
Chen Y, Trofe J, Gordon J, Autissier P, Woodle ES, Koralnik IJ. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. ClinVirol. 2009;42(2):198–202.
Ramaswami B, Popescu L, Macedo C, Metes D, Bueno M, Zeevi A, et al. HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen. Hum Immunol. 2009;70(9):722–8.
Article CAS PubMed PubMed Central Google Scholar
Cioni M, Leboeuf C, Comoli P, Ginevri F, Hirsch HH. Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses. Am J Transplant. 2016;16(4):1193–206.
Comments (0)